METTL14 and hepatocellular carcinoma: In liver cancer, Ma et al.86 reported that METTL14 plays a tumor-suppressor role in hepatocellular carcinoma (HCC), in which METTL14 and m6A levels were decreased compared to normal tissue or paratumor controls, with largely unchanged levels of METTL3 and WTAP.